Gabon vs Syria: The number of people with susceptibility test result for rifampicin
Gabon
807
in 2021
Syria
705
in 2021
Gabon rank
70th
Syria rank
71st
The number of people with susceptibility test result for rifampicin over time
- Gabon
- Syria
How they compare
Gabon currently reports 807 against 705 in Syria, a difference of 102.
That makes Gabon's figure about 1.1 times Syria's.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Gabon ahead.
Gabon ranks 70th and Syria ranks 71st of 155 countries.
Across the 2 decades both report, Gabon averaged higher in 1 and Syria in 1.
Head to head by decade
| Decade | Gabon | Syria | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1,104 | 491.33 | 612.67 | Gabon |
| 2020s | 722 | 808.5 | 86.5 | Syria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Gabon or Syria?
- Gabon, at 807 against 705 in Syria as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Gabon and Syria?
- 102, with Gabon ahead.
- How many years of comparable data are there for Gabon and Syria?
- 5 years are reported by both, from 2017 to 2021.
- How do Gabon and Syria rank globally for the number of people with susceptibility test result for rifampicin?
- Gabon ranks 70th and Syria ranks 71st of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.